Loading...
Loading...
India's semaglutide imports from DENMARK total $138.7B across 182 shipments from 15 foreign suppliers. NOVO NORDISK A/S leads with $138.1B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include NOVO NORDISK INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for semaglutide — a diversified sourcing base with multiple active suppliers from DENMARK.

NOVO NORDISK A/S is the leading Semaglutide supplier from DENMARK to India, with import value of $138.1B across 107 shipments. The top 5 suppliers — NOVO NORDISK A/S, NOVO NORDISK A S, NOVO NORDISK AS, ESPEE BIOPHARMA & FINECHEM LLC, ORIFARM SUPPLY S.R.O. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVO NORDISK A/S | $138.1B | 107 | 99.6% |
| 2 | NOVO NORDISK A S | $547.9M | 13 | 0.4% |
| 3 | NOVO NORDISK AS | $2.1M | 9 | 0.0% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $625.7K | 3 | 0.0% |
| 5 | ORIFARM SUPPLY S.R.O. | $224.2K | 7 | 0.0% |
| 6 | NEWLIFE BIOPHARMA LIMITED | $132.5K | 8 | 0.0% |
| 7 | ABACUS MEDICINE A/S | $68.5K | 1 | 0.0% |
| 8 | PRIVAPOSERVICES GMBH | $32.4K | 5 | 0.0% |
| 9 | E PHARM LIMITED | $31.7K | 2 | 0.0% |
| 10 | M S CATALENT GERMANY SCHORNDORF GMBH | $26.4K | 7 | 0.0% |
| 11 | XXVO XXRDIXX A X | $24.0K | 2 | 0.0% |
| 12 | SPRING BIO SOLUTION. | $20.8K | 3 | 0.0% |
| 13 | REGIONAL PHARMACY | $12.8K | 2 | 0.0% |
| 14 | AMSTERDAM PHARMA (APTEKA RX INC) | $7.0K | 2 | 0.0% |
| 15 | DERMA&DERMA COM.PRODS.DERM.FARM.LTDA(AMHO) | $5.9K | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVO NORDISK INDIA PRIVATE LIMITED | $138.7B | 129 | 100.0% |
| 2 | FISHER BIOPHARMA SERVICES INDIA PRIVATE LIMITED | $840.3K | 2 | 0.0% |
| 3 | AUROBINDO PHARMA LTD | $548.8K | 1 | 0.0% |
| 4 | ZYDUS LIFESCIENCES LIMITED | $383.2K | 14 | 0.0% |
| 5 | DR.REDDY'S LABORATORIES LTD | $76.9K | 2 | 0.0% |
| 6 | ALKEM LABORATORIES LIMITED | $73.3K | 3 | 0.0% |
| 7 | CIPLA LIMITED | $42.4K | 9 | 0.0% |
| 8 | FISHER BIOPHARMA SERVICES INDIA PVT LTD | $28.2K | 5 | 0.0% |
| 9 | PRECISE BIO PHARMA PRIVATE LIMITED | $25.4K | 4 | 0.0% |
| 10 | FISHER BIOPHARMA SERVICES (INDIA) PRIVATE LIMITED | $24.0K | 2 | 0.0% |
| 11 | INTAS PHARMACEUTICALS LIMITED | $11.0K | 5 | 0.0% |
| 12 | AUROBINDO PHARMA LIMITED | $11.0K | 1 | 0.0% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.8K | 3 | 0.0% |
| 14 | INTAS PHARMACEUTICALS LTD. | $1.9K | 1 | 0.0% |
| 15 | BIOCON LIMITED | $416 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Semaglutide suppliers from DENMARK to India include NOVO NORDISK A/S, NOVO NORDISK A S, NOVO NORDISK AS. The leading supplier is NOVO NORDISK A/S with import value of $138.1B USD across 107 shipments. India imported Semaglutide worth $138.7B USD from DENMARK in total across 182 shipments.
India imported Semaglutide worth $138.7B USD from DENMARK across 182 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Semaglutide sourced from DENMARK include NOVO NORDISK INDIA PRIVATE LIMITED, FISHER BIOPHARMA SERVICES INDIA PRIVATE LIMITED, AUROBINDO PHARMA LTD. The largest buyer is NOVO NORDISK INDIA PRIVATE LIMITED with $138.7B in imports across 129 shipments.
The total value of Semaglutide imports from DENMARK to India is $138.7B USD, across 182 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
182 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists